Pralong F P, Pavlou S N, Waldstreicher J, Crowley W F, Boepple P A
National Center for Infertility Research, Massachusetts General Hospital, Boston 02114, USA.
J Clin Endocrinol Metab. 1995 Dec;80(12):3682-8. doi: 10.1210/jcem.80.12.8530620.
During long term replacement with a GnRH regimen that restores their gonadotropin and sex steroid levels to normal, men with idiopathic hypogonadotropic hypogonadism (IHH) exhibit excessive secretion of pituitary free alpha-subunit (FAS). To characterize further the dose and duration of exogenous GnRH required to elicit this response, FAS, LH, FSH, and testosterone were determined during the first 8 weeks of GnRH administration in 10 men with IHH. The GnRH dose was increased stepwise every 2 weeks from 5 to 100 ng/kg every 2 h. Hormonal responses were compared with normative data for both pubertal boys and adult men. Low baseline levels of LH (mean +/- SEM, 0.9 +/- 0.03 IU/L), FSH (2.5 +/- 0.4 IU/L), FAS (148 +/- 21 ng/L), and testosterone (2.5 +/- 0.3 nmol/L) increased progressively after GnRH replacement. Mean FAS levels and pulse amplitudes significantly exceeded those in normal adult men by 4-6 weeks when their LH responses to GnRH administration remained below adult norms. By week 8 (50 ng GnRH/kg every 2 h), mean levels of LH, FSH, and FAS (13.7 +/- 2.1 IU/L, 15.4 +/- 4.0 IU/L, 627 +/- 75 ng/L, respectively) significantly exceeded adult male concentrations (P < 0.03). However, mean LH and FSH concentrations were not significantly different from midpubertal controls, in whom FAS levels were comparable to those in normal adults, verifying the excessive nature of FAS secretion relative to intact gonadotropins in the IHH patients. As this imbalance between FAS and dimeric gonadotropin secretion was established early in the current study when low doses of GnRH presumably resulted in low levels of receptor occupancy in vivo, it does not appear to result from partial pituitary desensitization induced by pharmacological GnRH stimulation. Rather, it appears to represent an inherent property of the GnRH-deficient state that is unmasked when GnRH input to the pituitary is restored. Further work will be necessary to elucidate the mechanism of this apparent defect in FAS regulation in GnRH-deficient men.
在用促性腺激素释放激素(GnRH)方案进行长期替代治疗,使促性腺激素和性类固醇水平恢复正常的过程中,特发性低促性腺激素性性腺功能减退(IHH)男性会出现垂体游离α亚基(FAS)分泌过多的情况。为了进一步明确引发这种反应所需的外源性GnRH剂量和持续时间,我们对10例IHH男性在GnRH给药的前8周内测定了FAS、促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮。GnRH剂量每2周从每2小时5 ng/kg逐步增加至100 ng/kg。将激素反应与青春期男孩和成年男性的标准数据进行比较。GnRH替代治疗后,LH(平均±标准误,0.9±0.03 IU/L)、FSH(2.5±0.4 IU/L)、FAS(148±21 ng/L)和睾酮(2.5±0.3 nmol/L)的低基线水平逐渐升高。当他们对GnRH给药的LH反应仍低于成人标准时,平均FAS水平和脉冲幅度在4 - 6周时显著超过正常成年男性。到第8周(每2小时50 ng GnRH/kg)时,LH、FSH和FAS的平均水平(分别为13.7±2.1 IU/L、15.4±4.0 IU/L、627±75 ng/L)显著超过成年男性浓度(P < 0.03)。然而,平均LH和FSH浓度与青春期中期对照组无显著差异,青春期中期对照组的FAS水平与正常成年人相当,这证实了IHH患者中FAS相对于完整促性腺激素分泌过多的性质。由于在本研究早期,当低剂量的GnRH可能导致体内受体占有率较低时,FAS和二聚体促性腺激素分泌之间的这种失衡就已确立,所以它似乎不是由药理学GnRH刺激引起的部分垂体脱敏导致的。相反,它似乎代表了GnRH缺乏状态的一种固有特性,当垂体的GnRH输入恢复时就会显现出来。需要进一步的研究来阐明GnRH缺乏男性中这种FAS调节明显缺陷的机制。